An Effective Technology for the Development of Immediate Release Solid Dosage Forms Containing Low-Dose Drug: Fused Deposition Modeling 3D Printing
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2655-y
Surface Modification of Polymeric Nanoparticles with M2pep Peptide for Drug Delivery to Tumor-Associated Macrophages
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2596-5
Sizing up the Next Generation of Nanomedicines
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2736-y
The Natural Product Eugenol Is an Inhibitor of the Ebola Virus In Vitro
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2629-0
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2651-2
ApoE-2 Brain-Targeted Gene Therapy Through Transferrin and Penetratin Tagged Liposomal Nanoparticles
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2691-7
A Single Hydrogen to Fluorine Substitution Reverses the Trend of Surface Composition Enrichment of Sorafenib Amorphous Solid Dispersion upon Moisture Exposure
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2632-5
Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2665-9
A Multifunctional Hydrogel Delivers Gold Compound and Inhibits Human Lung Cancer Xenograft
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2581-z
Polymeric Micellar Formulation Enhances Antimicrobial and Anticancer Properties of Salinomycin
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2615-6
Why Wait? The Case for Treating Tuberculosis with Inhaled Drugs
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2704-6
Development and Characterization of a Dry Powder Formulation for Anti-Tuberculosis Drug Spectinamide 1599
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2666-8
Multi-Solvent Microdroplet Evaporation: Modeling and Measurement of Spray-Drying Kinetics with Inhalable Pharmaceutics
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2630-7
Efficacy of Surface-Modified PLGA Nanoparticles as a Function of Cervical Cancer Type
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2602-y
Nanomedicines for Infectious Diseases
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2603-x
Heat Enhanced Follicular Delivery of Isotretinoin to the Skin
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2659-7
In vitro Pharmacokinetic Cell Culture System that Simulates Physiologic Drug and Nanoparticle Exposure to Macrophages
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2576-9
Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2613-8
Assessing the Utility of In Vitro Screening Tools for Predicting Bio-Performance of Oral Peptide Delivery
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2682-8
Formation of Protein Corona on Nanoparticle Affects Different Complement Activation Pathways Mediated by C1q
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2747-8
Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2702-8
Polyelectrolyte Carboxymethyl Cellulose for Enhanced Delivery of Doxorubicin in MCF7 Breast Cancer Cells: Toxicological Evaluations in Mice Model
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2598-3
Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2698-0
E-Jet 3D-Printed Scaffolds as Sustained Multi-Drug Delivery Vehicles in Breast Cancer Therapy
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2687-3
Octreotide Nanoparticles Showed Affinity for In Vivo MIA Paca-2 Inducted Pancreas Ductal Adenocarcinoma Mimicking Pancreatic Polypeptide-Secreting Tumor of the Distal Pancreas (PPoma)
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2678-4
Mucins are Involved in the Intestinal Permeation of Lipophilic Drugs in the Proximal Region of Rat Small Intestine
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2701-9
Surface Composition and Formulation Heterogeneity of Protein Solids Produced by Spray Drying
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2738-9
Impact of a Heat Shock Protein Impurity on the Immunogenicity of Biotherapeutic Monoclonal Antibodies
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2586-7
How Full-Length FVIII Benefits from Its Heterogeneity – Insights into the Role of the B-Domain
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2599-2
A Comprehensive Preclinical Evaluation of Intravenous Etoposide Lipid Emulsion
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2637-0
A Sialylated-Bortezomib Prodrug Strategy Based on a Highly Expressed Selectin Target for the Treatment of Leukemia or Solid Tumors
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2714-4
Challenging the CNS Targeting Potential of Systemically Administered Nanoemulsion Delivery Systems: a Case Study with Rapamycin-Containing Fish Oil Nanoemulsions in Mice
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2667-7
Minimum Interfacial Bonding Strength for Bilayer Tablets Determined Using a Survival Test
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2675-7
Proton Oriented-“Smart Depot” for Responsive Release of Ca2+ to Inhibit Peptide Acylation in PLGA Microspheres
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2640-5
Challenges and Opportunities for Patient Centric Drug Product Design: Industry Perspectives
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2616-5
Mathematical Modeling and Simulation to Investigate the CNS Transport Characteristics of Nanoemulsion-Based Drug Delivery Following Intranasal Administration
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2610-y
Ophthalmic Drug Discovery and Development: Regulatory Aspects of Patient Focused Drug Development in Ophthalmology
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2577-8
A Flow Cytometric Method to Quantify the Endosomal Escape of a Protein Toxin to the Cytosol of Target Cells
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2725-1
Differentiating the Effects of Oxidative Stress Tests on Biopharmaceuticals
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2627-2
On-Demand Manufacturing of Direct Compressible Tablets: Can Formulation Be Simplified?
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2716-2
Thrifty, Rapid Intestinal Monolayers (TRIM) Using Caco-2 Epithelial Cells for Oral Drug Delivery Experiments
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2712-6
Editorial to Theme Issue on Cell Based Therapeutics
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2573-z
The Duration of Nerve Block from Local Anesthetic Formulations in Male and Female Rats
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2715-3
Does Older Age Lead to Higher Risk for Neutropenia in Patients Treated with Paclitaxel?
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2697-1
Correction to: Evaluation of Wound Healing Potential of β-Chitin Hydrogel/Nano Zinc Oxide Composite Bandage
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2623-6
Correction to: Multi-Solvent Microdroplet Evaporation: Modeling and Measurement of Spray-Drying Kinetics with Inhalable Pharmaceutics
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2648-x
Exposure to Docetaxel in the Elderly Patient Population: a Population Pharmacokinetic Study
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2706-4
Application of Magnetic Resonance to Assess Lyophilized Drug Product Reconstitution
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2591-x
Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2628-1
Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model
来源期刊:Pharmaceutical ResearchDOI:10.1007/s11095-019-2638-z